A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

NCT02684032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gedatolisib
DRUG: Palbociclib
DRUG: Letrozole
DRUG: Fulvestrant

Sponsor

Celcuity Inc